California 2023-2024 Regular Session

California Assembly Bill AB853

Introduced
2/14/23  
Introduced
2/14/23  
Refer
2/23/23  
Report Pass
3/15/23  
Report Pass
3/15/23  
Refer
3/16/23  
Refer
3/20/23  
Refer
3/20/23  
Report Pass
3/28/23  
Report Pass
3/28/23  
Refer
3/30/23  
Refer
3/30/23  
Refer
5/3/23  
Refer
5/3/23  
Report Pass
5/18/23  
Report Pass
5/18/23  
Engrossed
5/30/23  
Engrossed
5/30/23  
Refer
5/31/23  
Refer
5/31/23  
Refer
6/7/23  
Refer
6/7/23  
Report Pass
7/3/23  
Report Pass
7/3/23  
Refer
7/3/23  
Report Pass
7/12/23  
Report Pass
7/12/23  
Refer
7/13/23  
Refer
7/13/23  
Refer
8/14/23  
Refer
8/14/23  
Report Pass
9/1/23  
Report Pass
9/1/23  
Enrolled
9/7/23  
Chaptered
10/8/23  

Caption

Retail grocery stores and retail drug stores: acquisition: notice to Attorney General.

Impact

The bill seeks to address the growing concern over the consolidation in the retail grocery and pharmacy sectors, which are critical for distributing food and medication in California. By requiring notification and a review period, AB 853 aims to allow for scrutiny of how such consolidations may affect market dynamics, potentially influencing supply, pricing, and availability of essential goods. Additionally, it protects the rights of workers in these industries by implementing a transition period for eligible grocery employees when acquisitions take place.

Summary

Assembly Bill No. 853, titled as 'Retail grocery stores and retail drug stores: acquisition: notice to Attorney General', has been established to regulate the acquisition processes related to retail grocery and drug firms in California. The bill mandates that any person intending to acquire voting securities or assets of these businesses must provide notice to the Attorney General at least 180 days prior to the effective date of such acquisitions. The purpose of this regulation is to ensure the Attorney General has adequate time to analyze the implications of these transactions, especially concerning public health and market competition.

Sentiment

Overall, the sentiment towards AB 853 appears supportive among lawmakers concerned with public welfare and competitive market practices. Advocates argue that this measure provides necessary tools for regulatory oversight and safeguards for consumers and quality employment. However, there is also potential concern from industry stakeholders who may perceive this as an additional regulatory burden that could impede business operations and deter investment in the sector.

Contention

A notable point of contention surrounding the bill is the balance between regulatory oversight and the rights of businesses to operate freely. Some critics argue that the 180-day notice requirement could delay necessary acquisitions that could enhance operational efficiency. There's also concern regarding the implications of expanding the perjury provisions linked to the notice requirements, which may impose significant legal penalties for violations. As such, the discussion around AB 853 is reflective of broader debates on how to regulate commerce in a way that protects public interests without stifling economic growth.

Companion Bills

No companion bills found.

Similar Bills

CA AB3129

Health care system consolidation.

PA HB2012

Providing for cause of action for antitrust conduct, for indirect purchaser recovery under State antitrust laws and for premerger notice of health care mergers and transactions; and imposing penalties.

CA SB966

Pharmacy benefits.

CA SB41

Pharmacy benefits.

CA AB2817

Office of Health Care Quality and Affordability.

PA HB1371

Establishing cause of action for antitrust conduct, for indirect purchaser recovery under State antitrust laws and for premerger notice of health care mergers and transactions; and imposing penalties.

CT SB00411

An Act Concerning The Insurance Holding Company System Regulatory Act.

DC B26-0030

Uniform Antitrust Pre-Merger Notification Act of 2025